Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Baranello

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Neuromuscular Disorders : NMD|August 7, 2024
Risk-benefit profile of onasemnogene abeparvovec in older and heavier children with spinal muscular atrophy type 1Rebecca Finnegan, Adnan Manzur, Pinki Munot, et al.
Neuromuscular Disorders : NMD|July 16, 2023
Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trialRichard D Shell, Katlyn E McGrattan, Rebecca Hurst-Davis, et al.
Clinical Neuroradiology|January 25, 2020
Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular DystrophyLorenzo Maggi, Marco Moscatelli, Rita Frangiamore, et al.
American Journal of Medical Genetics. Part A|September 13, 2011
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivityPaolo Alfieri, Laura Cesarini, Paola De Rose, et al.
Sleep Medicine|January 16, 2014
Sleep disorders in children with cerebral palsy: neurodevelopmental and behavioral correlatesDomenico M Romeo, Claudia Brogna, Michela Quintiliani, et al.
Journal of Neuromuscular Diseases|January 8, 2024
Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great BritainNikki Cornell, Anne-Marie Childs, Elizabeth Wraige, et al.
Neurology. Genetics|March 16, 2026
Genetic Landscape and Diagnostic Outcomes of UK Patients With Congenital Myopathies and Muscular Dystrophies Over a 10-Year PeriodGianpaolo Cicala, Jo Mccauley, Rahul Phadke, et al.
Early Human Development|February 28, 2006
Thalamic atrophy in infants with PVL and cerebral visual impairmentDaniela Ricci, Shirley Anker, Frances Cowan, et al.
Biomedicines|January 30, 2020
Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA PatientsSilvia Bonanno, Stefania Marcuzzo, Claudia Malacarne, et al.
Neuropediatrics|December 25, 2014
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care?Flaviana Bianco, Marika Pane, Adele D'Amico, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Neuromuscular Disorders : NMD|August 7, 2024
Risk-benefit profile of onasemnogene abeparvovec in older and heavier children with spinal muscular atrophy type 1Rebecca Finnegan, Adnan Manzur, Pinki Munot, et al.
Neuromuscular Disorders : NMD|July 16, 2023
Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trialRichard D Shell, Katlyn E McGrattan, Rebecca Hurst-Davis, et al.
Clinical Neuroradiology|January 25, 2020
Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular DystrophyLorenzo Maggi, Marco Moscatelli, Rita Frangiamore, et al.
American Journal of Medical Genetics. Part A|September 13, 2011
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivityPaolo Alfieri, Laura Cesarini, Paola De Rose, et al.
Sleep Medicine|January 16, 2014
Sleep disorders in children with cerebral palsy: neurodevelopmental and behavioral correlatesDomenico M Romeo, Claudia Brogna, Michela Quintiliani, et al.
Journal of Neuromuscular Diseases|January 8, 2024
Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great BritainNikki Cornell, Anne-Marie Childs, Elizabeth Wraige, et al.
Neurology. Genetics|March 16, 2026
Genetic Landscape and Diagnostic Outcomes of UK Patients With Congenital Myopathies and Muscular Dystrophies Over a 10-Year PeriodGianpaolo Cicala, Jo Mccauley, Rahul Phadke, et al.
Early Human Development|February 28, 2006
Thalamic atrophy in infants with PVL and cerebral visual impairmentDaniela Ricci, Shirley Anker, Frances Cowan, et al.
Biomedicines|January 30, 2020
Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA PatientsSilvia Bonanno, Stefania Marcuzzo, Claudia Malacarne, et al.
Neuropediatrics|December 25, 2014
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care?Flaviana Bianco, Marika Pane, Adele D'Amico, et al.
Pageof 18